All Content

Psychotherapists

For Everyone

Drug Developers

About

Webinar

Loading description...
Loading...

October 21, 2025 at 1:00 PM ET

Online

Loading...
Flexible payment options available

WEbinar

Loading description...
Loading...

October 21, 2025 at 1:00 PM ET

Online

Loading...
Flexible payment options available

Webinar

Loading description...
Loading...

October 21, 2025 at 1:00 PM ET

Online

Loading...
Flexible payment options available

Overview

Why attend this webinar?

In this live webinar, Lauren Okano, PhD, MS, will be joined by Dan Roberts, MD, MSW, to explore the evolving landscape shaping best practices in psychedelic therapy. Together they will examine historical context and emerging research, focusing on how practice standards are being developed and applied across both research and clinical settings. As psychedelic therapy moves toward broader clinical adoption, questions of standardization, evidence-based protocols, and adaptability are key to ensuring safe, ethical, and effective care.

Our discussion will highlight how rigorous standards of practice are emerging within clinical trials, how these approaches inform (and sometimes diverge from) real-world clinical practice, and what this means for therapists seeking to deliver patient-centered care. We’ll also explore the challenges and opportunities of translating research frameworks into flexible, responsive approaches for diverse client needs.

Dan Roberts, MD, MSW, is a board-certified psychiatrist and Assistant Professor of Psychiatry at the NYU Grossman School of Medicine, where he is a clinician-researcher at the Center for Psychedelic Medicine and attending psychiatrist at the World Trade Center Health Program. He has served as a study physician and lead therapist on over seven psychedelic-assisted therapy clinical trials and is deeply involved in training and supervising psychedelic therapists through NYU, Fluence, and the MAPS Public Benefit Corporation. With a foundation in both social work and psychiatry, Dan brings unique expertise in bridging research and clinical delivery in psychedelic therapy.

Participants will gain insights into:

  • The role of standardization in shaping methodology, procedures, and analysis in psychedelic therapy

  • The benefits and limitations of protocolized approaches for clinical and community-based practice

This CE-granting session will benefit clinicians, students, researchers, and anyone interested in how psychedelic-assisted therapy is evolving across contexts.

The webinar will conclude with a live Q&A. A recording will be sent to everyone who registers, so sign up even if you can’t attend live.

Continuing Education Information

Topic

Best Practices

Psychedelics

Type

Webinar

Overview

Why attend this webinar?

In this live webinar, Lauren Okano, PhD, MS, will be joined by Dan Roberts, MD, MSW, to explore the evolving landscape shaping best practices in psychedelic therapy. Together they will examine historical context and emerging research, focusing on how practice standards are being developed and applied across both research and clinical settings. As psychedelic therapy moves toward broader clinical adoption, questions of standardization, evidence-based protocols, and adaptability are key to ensuring safe, ethical, and effective care.

Our discussion will highlight how rigorous standards of practice are emerging within clinical trials, how these approaches inform (and sometimes diverge from) real-world clinical practice, and what this means for therapists seeking to deliver patient-centered care. We’ll also explore the challenges and opportunities of translating research frameworks into flexible, responsive approaches for diverse client needs.

Dan Roberts, MD, MSW, is a board-certified psychiatrist and Assistant Professor of Psychiatry at the NYU Grossman School of Medicine, where he is a clinician-researcher at the Center for Psychedelic Medicine and attending psychiatrist at the World Trade Center Health Program. He has served as a study physician and lead therapist on over seven psychedelic-assisted therapy clinical trials and is deeply involved in training and supervising psychedelic therapists through NYU, Fluence, and the MAPS Public Benefit Corporation. With a foundation in both social work and psychiatry, Dan brings unique expertise in bridging research and clinical delivery in psychedelic therapy.

Participants will gain insights into:

  • The role of standardization in shaping methodology, procedures, and analysis in psychedelic therapy

  • The benefits and limitations of protocolized approaches for clinical and community-based practice

This CE-granting session will benefit clinicians, students, researchers, and anyone interested in how psychedelic-assisted therapy is evolving across contexts.

The webinar will conclude with a live Q&A. A recording will be sent to everyone who registers, so sign up even if you can’t attend live.

Continuing Education Information

Topic

Best Practices

Psychedelics

Type

Webinar

Overview

Why attend this webinar?

In this live webinar, Lauren Okano, PhD, MS, will be joined by Dan Roberts, MD, MSW, to explore the evolving landscape shaping best practices in psychedelic therapy. Together they will examine historical context and emerging research, focusing on how practice standards are being developed and applied across both research and clinical settings. As psychedelic therapy moves toward broader clinical adoption, questions of standardization, evidence-based protocols, and adaptability are key to ensuring safe, ethical, and effective care.

Our discussion will highlight how rigorous standards of practice are emerging within clinical trials, how these approaches inform (and sometimes diverge from) real-world clinical practice, and what this means for therapists seeking to deliver patient-centered care. We’ll also explore the challenges and opportunities of translating research frameworks into flexible, responsive approaches for diverse client needs.

Dan Roberts, MD, MSW, is a board-certified psychiatrist and Assistant Professor of Psychiatry at the NYU Grossman School of Medicine, where he is a clinician-researcher at the Center for Psychedelic Medicine and attending psychiatrist at the World Trade Center Health Program. He has served as a study physician and lead therapist on over seven psychedelic-assisted therapy clinical trials and is deeply involved in training and supervising psychedelic therapists through NYU, Fluence, and the MAPS Public Benefit Corporation. With a foundation in both social work and psychiatry, Dan brings unique expertise in bridging research and clinical delivery in psychedelic therapy.

Participants will gain insights into:

  • The role of standardization in shaping methodology, procedures, and analysis in psychedelic therapy

  • The benefits and limitations of protocolized approaches for clinical and community-based practice

This CE-granting session will benefit clinicians, students, researchers, and anyone interested in how psychedelic-assisted therapy is evolving across contexts.

The webinar will conclude with a live Q&A. A recording will be sent to everyone who registers, so sign up even if you can’t attend live.

Continuing Education Information

Topic

Best Practices

Psychedelics

Type

Webinar

Grow your practice.

Get certified and join the Fluence Psychedelic Therapy Directory—where clients find trusted experts.

Grow your practice.

Get certified and join the Fluence Psychedelic Therapy Directory—where clients find trusted experts.

Grow your practice.

Get certified and join the Fluence Psychedelic Therapy Directory—where clients find trusted experts.

What students have to say about our programs...

  • I really appreciate Fluence. The trainings and coursework, the literature shared, the community, self-development and insightful explorations have strengthened me as a professional and given such a sense of competence in this evolving space.

    Amy Johnson

    LCSW

  • I've been more than thrilled about my experience with Fluence thus far. I am a ketamine-assisted psychotherapist and

    continue to learn more information and modalities to incorporate into my practice, from both the instructors and

    fellow students.

    LAURA HUTCHINS,

    LCMHC, LCAS, KAP Consulting

  • My entire experience with Fluence has been exceptional. The instructors are giants in the psychedelic field, many are active in clinical research and you will see their names in scientific publications.

    Stephanie Barss,

    FNP, PMHNP, Psilocybin-Assisted Therapy

    Certificate Program Advisor

  • The trainers at Fluence are what continually confirm that I am in the right place. The reverence and honor with which they approach their work is so evident. I have felt a sense of safety

    at Fluence that is not present in other organizations I have

    trained with or researched, and it is the trainers who create that safety.

    Andrea Bigenho,

    LPC specialist in Psychedelic Integration

What are students say…

I really appreciate Fluence. The trainings and coursework, the literature shared, the community, self-development and insightful explorations have strengthened me as a professional and given such a sense of competence in this evolving space.

Amy Johnson,

LCSW

What students have to say about our programs...

I really appreciate Fluence. The trainings and coursework, the literature shared, the community, self-development and insightful explorations have strengthened me as a professional and given such a sense of competence in this evolving space.

Amy Johnson,

LCSW

Authorized provider of continuing education.

Fluence is approved by the American Psychological Association to sponsor continuing education for psychologists.

Fluence maintains responsibility for this program and its content.

Authorized provider of continuing education.

Fluence is approved by the American Psychological Association to sponsor continuing education for psychologists.

Fluence maintains responsibility for this program and its content.

Authorized provider of continuing education.

Fluence is approved by the American Psychological Association to sponsor continuing education for psychologists.

Fluence maintains responsibility for this program and its content.